United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension
Ralinepag has the potential to be the first once-a-day oral prostacyclin agonist for patients with pulmonary arterial hypertension ADVANCE OUTCOMES will continue... Read more.
Juicy Couture Expands Beauty Offerings with Centric Brands Partnership
New collection of cruelty-free Juicy Couture beauty and bath products to launch across U.S. and Canada NEW YORK–(BUSINESS WIRE)–#centricbrands–Juicy... Read more.
Provi Welcomes Chief Product and Technology Officer to Drive Digital Growth and Innovation in Beverage Alcohol
Qingqing Ouyang joins Provi’s executive team to scale its product and technology capabilities across the wholesale ecosystem CHICAGO–(BUSINESS WIRE)–Provi,... Read more.
Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy... Read more.
Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal Year 2026 Results
EL PASO, Texas–(BUSINESS WIRE)–Helen of Troy Limited (NASDAQ: HELE), designer, developer, and worldwide marketer of branded consumer home, outdoor, beauty,... Read more.
Digital Commerce Market Outlook Report 2025-2029: Digital Commerce Spend to Hit $34 Trillion by 2029 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Digital Commerce Market: 2025-2029” report has been added to ResearchAndMarkets.com’s offering. The Digital... Read more.
DNA Payments and MWC Partners launch Dynamics 365 Commerce integration
LONDON–(BUSINESS WIRE)–DNA Payments has announced its latest strategic partnership with MWC Partners, a leading provider of omnichannel Retail POS technology.... Read more.
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that... Read more.
Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
A single administration of COMP360 demonstrated a highly statistically significant and clinically meaningful reduction in symptom severity as measured by MADRS1... Read more.
Media Reminder: Grand Opening Celebration of Senior Housing in Gravette, Arkansas
***1:00 p.m., Tuesday, June 24, 501 Dallas Street SW, Gravette, Arkansas 72736*** GRAVETTE, Ark.–(BUSINESS WIRE)–#affordablehousing–Representatives... Read more.